Could SARS-CoV-2 blocking of ACE2 in endothelial cells result in upregulation of CX3CL1, promoting thrombosis in COVID-19 patients?

SARS-CoV-2 is the causal agent of COVID-19 disease. Currently, infection with SARS-CoV-2 has been the cause of death of over 2.5 million people globally, and there is still no effective curative treatment. Clinically, the severe symptoms caused by COVID-19, in addition to pneumonia, are associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivas-Fuentes, Selma, Valdés, Víctor Julián, Espinosa, Blanca, Gorocica-Rosete, Patricia, Salgado-Aguayo, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992310/
https://www.ncbi.nlm.nih.gov/pubmed/33836338
http://dx.doi.org/10.1016/j.mehy.2021.110570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992310/
https://www.ncbi.nlm.nih.gov/pubmed/33836338
http://dx.doi.org/10.1016/j.mehy.2021.110570

Ejemplares similares